SEARCHSITE

About Coronary Artery Disease

Coronary Artery Disease, or CAD, develops when the major blood vessels in the heart (coronary arteries) that supply your heart with blood, oxygen and nutrients become damaged or diseased. Cholesterol-containing deposits (plaque) in your arteries and inflammation are usually to blame for coronary artery disease1. CAD is responsible for killing over 370,000 people annually2. In the united states, more than 2.3 million coronary interventions were performed in 20173. High blood pressure, high cholesterol, and diabetes are some conditions that increase the risk of developing coronary artery disease4. Physical inactivity, obesity, tobacco use, and an unhealthy diet are also contributing factors to the development of CAD4.

Symptoms of CAD include chest pain or discomfort, shortness of breath, nausea, lightheadedness or cold sweats, and upper body pain or discomfort in the arms, back, neck, jaw, or upper stomach. 5

Terumo Interventional systems offers a suite of products designed to meet specific challenges in treating coronary artery disease. With its radial specific and femoral offerings Terumo’s devices provide reliable access, navigation through tortuous anatomy, and crossing and treating complex lesions to improve quality of life.

Coronary Procedural Solutions

ACCESS

Glidesheath Slender

GLIDESHEATH SLENDER Introducer Sheath provides proven performance to support your transradial intervention needs.  The proprietary thin-wall technology reduces the outer diameter of the introducer sheath by one Fr size while maintaining larger inner-diameter equivalent. This feature, combined with Terumo’s hydrophilic coating, allows operators to optimize procedural outcomes while preserving arterial function.

GlidesheathSlender_withTag_rgb_transl

TARGET

Glidewire Baby-J
The TERUMO 1.5 mm GLIDEWIRE Baby-J Hydrophilic Coated Guidewire combines the leading performance of the GLIDEWIRE Guidewire product portfolio with design features ideal for transradial access.

Optitorque
A complete line of coronary diagnostic catheters designed for optimum torque control and precise placement.

Heartrail
A family of radial specific catheters that provides enhanced back up support in comparison to standard femoral guiding catheter shapes - resulting in simplified procedures.

Runthrough NS Extra Floppy
Designed to be your first-choice coronary guidewire. The RUNTHROUGH NS Extra Floppy is designed to be an all-in-one workhorse wire with a soft, atraumatic, low tip weight wire that can be used to access most every day and complex lesions.

Runthrough NS Hypercoat
Designed to be your complex coronary wire of choice. Runthrough NS Hypercoat is an enhanced hydrophilic guidewire for tortuous, distal lesions and tight stenotic complex lesions.

Finecross MG Microguide Catheter
Coronary microguide catheter for integration of optimal guidewire support, superior trackability and crossability.9

Glidewire BabyJ Logo
heartrail-logo
RunthroughNSHyper_withTag_rgb_transl
optitorque-logo
RunthroughNSextraFloppy_withTag_rgb_transl
finecross-logo

INTERVENE

Takeru PTCA Balloon Catheter
TAKERU PTCA Balloons are engineered to have the highest performance in reaching and crossing complex lesions. Deliver performance where it matters most.9

Priority One AC Aspiration Catheter
PRIORITYONE AC is an aspiration catheter with a guidewire-style stylet technology and a fully braided stainless-steel shaft improving deliverability through superior distal kink resistance in difficult clinical scenarios.9

Takeru-Black
PriorityOneAC_withTag_rgb_transl

CLOSE

TR Band
The #1 preferred radial hemostasis device on the market, provides precise compression of the radial artery without compromising local nerve structure. 9

Angio-Seal
Active closure for rapid hemostasis to accelerate patient mobility and enable same-day discharge. 6-8

TRBand-logo
Angio-Seal-logo

Indications
The Angio-Seal Vascular Closure Device product family, including the STS Plus, VIP and Evolution platforms, is indicated for use in closing and reducing time to hemostasis of the femoral arterial puncture site in patients who have undergone diagnostic angiography procedures or interventional procedures using an 8 French or smaller procedural sheath for the 8 F Angio-Seal device and a 6 French or smaller procedural sheath for the 6 F Angio-Seal device. The Angio-Seal STS Plus, VIP and Evolution platform devices are also indicated for use to allow patients who have undergone diagnostic angiography to safely ambulate as soon as possible after sheath removal and device placement, as well as to allow patients who have undergone an interventional procedure to safely ambulate after sheath removal and device placement.

Important Safety Information
Possible adverse events for vascular closure devices include, but are not limited to: bleeding or hematoma, AV fistula or pseudoaneurysm, infection, allergic reaction, foreign body reaction, inflammation or edema. This device should only be used by a licensed physician (or other health care professional authorized by or under the direction of such physician) possessing adequate instruction in the use of the device, e.g., participation in an Angio-Seal physician instruction program or equivalent.

RX ONLY. Refer to the product labels and package insert for complete warnings, precautions, potential complications, and instructions for use. 

References:

  1. https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/symptoms-causes/syc-20350613
  2. CDC, NCHS. Underlying Cause of Death 1999-2013 on CDC WONDER Online Database, released 2015. Data are from the Multiple Cause of Death Files, 1999-2013, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed Feb. 3, 2015.
  3. MRG Data 2017
  4. https://www.cdc.gov/heartdisease/behavior.htm
  5. https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heartattack.htm
  6. Manolis AS, Georgiopolis G, Stalikas D, Koulouris S. Simplified swift and safe vascular device deployment without a local arteriogram: Single center experience in 2074 consecutive patients. Indian Heart Journal. 2016; 68:529-538.
  7. Kapadia SR, Raymond R, Knopf W, Jenkins S, Chapekis A, Ansel G, Rothbaum D, Kussmaul W, Teirstein P, Reisman M, Casale P, Oster L, Simfendorfer C. The 6Fr Angio-Seal arterial closure device: Results from a multimember prospective registry. Am J Cardiol. 2001; 87:789-791.
  8. Antonsen L, Jensen LO, Thayssen P. Outcome and safety of same-day-discharge percutaneous coronary interventions with femoral access: a single-center experience. Am Heart J. 2013 Mar;165(3):393-9. doi: 10.1016/j.ahj.2012.11.009. Epub 2013 Jan 24.
  9. Data On File